series-c-plus
Stage
About
FBB Biomed develops an RNA-based analytics platform that uses RNA-seq and AI to provide a blood-based alternative to lumbar puncture for testing and monitoring neurologic diseases. The company is a private Delaware corporation operating out of Iowa and offers its platform for research use.
Explore FBB Biomed's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.